Journal of the American College of Cardiology 2021 Jun 8;77(22):2872-2873
Article disponible en consultant le siteAuteurs
Barthélémy O, Rouanet S, Zeymer U, Thiele H, Montalescot G.
Abstract
We thank Dr. Burgess and colleagues and Drs. Li and Ni for their comments and interest in our post hoc angiographic subanalysis of the CULPRIT SHOCK (Culprit Lesion Only Percutaneous Coronary Intervention [PCI] Versus Multivessel PCI in Cardiogenic Shock) trial. Among 587 patients with multivessel disease and myocardial infarction (MI)-related cardiogenic shock (CS): 1) we found that complete revascularization (CR) is achieved only in one-fourth of the patients treated using a multivessel-PCI strategy; and 2) for the first time, we demonstrated that the residual SYNTAX (SYNergy between PCI with TAXUS and Cardiac Surgery) score is independently associated with early and late mortality.
[...]
Achieving a more complete and safer revascularization as a staged procedure is surely reasonable based on the results of our analysis in patients with CS.
